Though Roku’s stock fell more than 15 percent after a disappointing earnings report Wednesday, CFO Steve Louden told Cheddar he is confident the company is positioned for success amid the ongoing streaming wars.
"We are the largest streaming platform in the U.S. and we have a neutral position amongst a lot of the different stakeholders within the ecosystem, which has served us well," he said.
Louden said Roku, a service that lets users access a variety of streaming services from one spot, is platform-agnostic, making it an "essential partner in the industry," noting that it will be an access point for both the new Apple TV+ and Disney+.
"If you’re a new service and you want to have a successful direct-to-consumer strategy, then you need to be on the number one platform in the U.S.," Louden said.
Though Roku’s stock was still down Thursday, Louden said he doesn’t worry about short-term fluctuations. In its Q3 earnings report, Roku noted users streamed 10.3 billion hours over the last quarter and reported a 50 percent revenue jump. Roku reported a loss of $26.5 million.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
